Ensifentrine is a medication with a novel mechanism of action for the maintenance treatment of chronic obstructive pulmonary disease.
chronic obstructive pulmonary disease (COPD)
Posted inAutoimmune Diseases, Clinical Trials
Apogee Therapeutics: Treating Eczema With Two Injections per Year
Biologic treatment for atopic dermatitis reaches a new level of convenience.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Tezspire: Effective Treatment for Severe Uncontrolled Asthma
Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.